Research: Increased risk of heart attacks & strokes for people with long COVID & ME/CFS

Long COVID & ME/CFS have similarly impaired vascular function

 

Researchers from Scotland found similar problems with the lining of the blood vessels (endothelium) in both people with long COVID and ME/CFS, in spite of people with ME/CFS being ill for much longer.

This suggests an increased cardiovascular risk, leading to heart attacks and strokes and “highlights the need for individuals with post-viral illnesses to be carefully monitored for cardiovascular risk and potentially prescribed treatments to lower risk.”

 

People with Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) exhibit similarly impaired vascular function, by Marie Mclaughlin, Nilihan E M Sanal-Hayes, Lawrence D Hayes, Ethan C Berry, Nicholas F Sculthorpe in Am J Med. 2023 Oct 11 [doi: 10.1016/j.amjmed.2023.09.013]

Research abstract

Background:
This study aimed to compare flow-mediated dilation values between individuals with Long COVID, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and healthy age-matched controls to assess the potential implications for clinical management and long-term health outcomes.

Methods:
A case-case-control approach was employed, and flow-mediated dilation measurements were obtained from 51 participants (17 Long COVID patients, 17 ME/CFS patients, and 17 healthy age-matched controls). Flow-mediated dilation values were analysed using one-way ANOVA for between-group comparisons.

Results:
Results revealed significantly impaired endothelial function in both Long COVID and ME/CFS groups compared to healthy age-matched controls as determined by maximum % brachial artery diameter post-occlusion compared to pre-occlusion resting diameter (6.99 ± 4.33% and 6.60 ± 3.48% vs. 11.30 ± 4.44%, respectively, both p < 0.05). Notably, there was no difference in flow-mediated dilation between Long COVID and ME/CFS groups (p = 0.949), despite significantly longer illness duration in the ME/CFS group (ME/CFS: 16 ± 11.15 years vs. Long COVID: 1.36 ± 0.51 years, p < 0.0001).

Conclusion:
The study demonstrates that both Long COVID and ME/CFS patients exhibit similarly impaired endothelial function, indicating potential vascular involvement in the pathogenesis of these post-viral illnesses. The significant reduction in flow-mediated dilation values suggests an increased cardiovascular risk in these populations, warranting careful monitoring and the development of targeted interventions to improve endothelial function and mitigate long-term health implications.

Posted in News | Comments Off on Research: Increased risk of heart attacks & strokes for people with long COVID & ME/CFS

WMEA calls on UN to address post-viral illnesses in future pandemic planning

32 organisations call for future pandemic preparedness to address infection-associated chronic conditions 

 

The World ME Alliance says future pandemic preparedness will fail millions without explicit recognition of and research into infection associate chronic conditions.

On 20th September 2023, the United Nations General Assembly adopted a Political Declaration on Pandemic Prevention, Preparedness and Response.

The commitments outlined in this declaration are vital for enhancing global readiness to tackle future pandemics effectively, yet they fail to address infection-associated chronic conditions.

Globally, more than 65 million people are now living with long COVID, of whom 50% meet the criteria for a diagnosis of ME/CFS and over 70% have developed dysautonomia. The need for recognition and expedited research to address these chronic illnesses is undeniable.

Facilitated by the World ME Alliance, 32 organizations, including WAMES, have joined in calling on His Excellency Mr Dennis Francis, President of the 78th UN General Assembly, to raise awareness of this critical issue within the UN and among member states, and meet with us to discuss working toward a healthier and more resilient world for all.

Extract from letter:

… historical records show that after previous pandemics and epidemics, from the Greek plague of 430 BC to the Spanish Flu of 1918 to the 2014 Ebola virus disease outbreak, there have been accounts of individuals who never fully recover, living with chronic illnesses that often mirror the symptoms of ME and dysautonomia. This pattern underscores the importance of recognizing infection-associated chronic illnesses as a recurring issue following pandemics, with long-lasting implications for affected individuals and society as a whole.

Therefore, we respectfully urge the United Nations and its member states to consider addressing this significant gap in pandemic preparedness and response. We call for future initiatives and strategies related to pandemic preparedness to explicitly include actions on the impact of infection-associated chronic illnesses, such as long COVID, ME, POTS and other forms of dysautonomia and more.

Vitally, these efforts should encompass research and recognition, with immediate recommendations to invest in research to understand the underlying mechanisms of these conditions, facilitate early diagnosis, and improve recognition, medical education and treatment.

We kindly request your support in raising awareness of this matter within the United Nations and among member states. We, the undersigned, are committed to providing aid and being a resource for the UN and member states in this endeavour. Together, we can work towards a more inclusive and responsive approach to pandemic preparedness that considers the long-term health and well-being of all individuals affected by infectious diseases.

32 organisations signed:

World ME Alliance – Global
Long Covid Alliance – Global
Dysautonomia International – Global
#MEAction – Global
12ME – Belgium
ACAF – Spain
Action for M.E. – UK
AMMES – The American ME and CFS Society
ANZMES – The Associated New Zealand Myalgic Encephalomyelitis Society
Associazione Italiana Long COVID – Italy
AQEM – Association québécoise de l’encéphalomyélite myalgique – Canada
CFS/ME Associazione Italiana – Italy
CFS/ME Organizzazione di Volontariato – Italy
European ME Coalition
Emerge Australia
Forward ME – UK
Hope 4 ME and Fibro Northern Ireland
Japan ME Association
ME CVS Nederland
ME Support (IOM) – Isle of Man
ME/CFS Israel
Millions Missing Belgique
Millions Missing Canada
Millions Missing France
Millions Missing Mexico
Mirame Arts – Germany
MYOS – Portugal
Neúnavní – Czechia
Plataforma Familiars FM-SFC-SQM Síndromes de Sensibilització Central – Spain
Solve M.E. – US
The ME CFS Foundation South Africa
WAMES – Welsh Association of ME & CFS Support

Read the complete article and letter

Download letter

 

Posted in News | Comments Off on WMEA calls on UN to address post-viral illnesses in future pandemic planning

Research: Diagnosing ME/CFS by analysing questionnaires with Machine Learning

Machine learning analysis of SF-36 Health questionnaire could be as diagnostic tool for ME/CFS

 

Spanish researchers looked for an alternative to using an expensive and invasive exercise test (CPET) as a diagnostic biomarker in patients with ME/CFS. They found that using Machine Learning to analyse the answers to the Short Form-36 (SF-36) questionnaire could predict oxygen consumption and reveal sub-types.

 

Unsupervised cluster analysis reveals distinct subtypes of ME/CFS patients based on peak oxygen consumption and SF-36 scores, by Marcos Lacasa, Patricia Launois, Ferran Prados, José Alegre, Jordi Casas-Roma in Clinical Therapeutics Oct 4, 2023 [doi.org/10.1016/j.clinthera.2023.09.007]

HIGHLIGHTS

  • ME/CFS is a disabling chronic disease with a lack of diagnostic tests.
  • Oxygen consumption is a possible biomarker of CFS.
  • O2 consumption allows classifying patients status according to the Weber’s classification.
  • A worse Weber’s classification infers a worse outcome on the SF-36 questionnaire.
  • Unsupervised machine learning is a powerful tool for analyzing data.

Research abstract

Purpose
Myalgic encephalomyelitis, commonly referred to as chronic fatigue syndrome (ME/CFS), is a severe, disabling chronic disease and an objective assessment of prognosis is crucial to evaluate the efficacy of future drugs. Attempts are ongoing to find a biomarker to objectively assess the health status of (ME/CFS), patients.

This study therefore aims to demonstrate that oxygen consumption is a biomarker of ME/CFS provides a method to classify patients diagnosed with ME/CFS based on their responses to the Short Form-36 (SF-36) questionnaire, which can predict oxygen consumption using cardiopulmonary exercise testing (CPET).

Methods
Two datasets were used in the study. The first contained SF-36 responses from 2,347 validated records of ME/CFS diagnosed participants, and an unsupervised machine learning model was developed to cluster the data. The second dataset was used as a validation set and included the cardiopulmonary exercise test (CPET) results of 239 participants diagnosed with ME/CFS. Participants from this dataset were grouped by peak oxygen consumption according to Weber’s classification.

he SF-36 questionnaire was correctly completed by only 92 patients, who were clustered using the machine learning model. Two categorical variables were then entered into a contingency table: the cluster with values {0,1} and Weber classification {A, B, C, D} were assigned. Finally, the Chi-square test of independence was used to assess the statistical significance of the relationship between the two parameters.

Findings
The results indicate that the Weber classification is directly linked to the score on the SF-36 questionnaire. Furthermore, the 36-response matrix in the machine learning model was shown to give more reliable results than the subscale matrix (p − value < 0.05) for classifying patients with ME/CFS.

Implications
Low oxygen consumption on CPET can be considered a biomarker in patients with ME/CFS. Our analysis showed a close relationship between the cluster based on their SF-36 questionnaire score and the Weber classification, which was based on peak oxygen consumption during CPET. The dataset for the training model comprised raw responses from the SF-36 questionnaire, which is proven to better preserve the original information, thus improving the quality of the model.

Posted in News | Comments Off on Research: Diagnosing ME/CFS by analysing questionnaires with Machine Learning

Research: ME/CFS & pregnancy

ME/CFS and pregnancy: a systematic review

 

When reviewing studies of pregnancy in women living with ME/CFS, researchers from Newcastle University found the impact of pregnancy on ME/CFS severity varied within and between the small number of relevant studies.

The importance of both individualised care, and of healthcare professionals learning about ME/CFS in relation to family planning and pregnancy was however highlighted.

There are currently no evidence-based guidelines for management of ME/CFS and pregnancy. People with ME/CFS, their partners and healthcare professionals are unable to make informed, evidence-based decisions around family planning, pregnancy, labour and birth.

“More research is urgently needed, considering all aspects of pregnancy and ME/CFS for patients and healthcare professionals. In particular, research should explore what would constitute high-quality care for those with ME/CFS relating to pregnancy and family planning.”

Better quality research is also needed, with larger sample sizes, healthy control groups, clearly defined research questions and a standard diagnostic criteria for ME/CFS.

 

Identifying, synthesising and appraising existing evidence relating to myalgic encephalomyelitis/chronic fatigue syndrome and pregnancy: a mixed-methods systematic review, by Emma Slack, Katrina Anne Pears, Judith Rankin, Julia L Newton, Mark Pearce in BMJ Open Volume 13, Issue 10, 2023

Research abstract:

Objectives

To identify, synthesise and appraise evidence relating to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and pregnancy.

Design

Mixed-methods systematic review, using convergent segregated design.

Data sources

MEDLINE, EMBASE, Scopus, PsycINFO, CINAHL, MedRxiv, PROSPERO and grey literature sources through 6 August 2023.

Eligibility criteria

We included original research studies, expert opinion and grey literature reporting on ME/CFS and pregnancy/post partum (up to 2 years), risk of pregnancy outcomes with ME/CFS or experiences during pregnancy for mother, partner or health and social care professionals following ME/CFS during pregnancy, all where the evidence was relevant to a confirmed ME/CFS diagnosis prior to pregnancy.

Data extraction and synthesis

Three independent reviewers completed all screening, data extraction and quality assessment. Risk of bias was assessed using the mixed-methods appraisal tool V.2018. Qualitative and quantitative literature was analysed separately using thematic and descriptive syntheses. Findings were integrated through configuration.

Results

Searches identified 3675 articles, 16 met the inclusion criteria: 4 quantitative (1 grey), 11 qualitative (9 grey) and 1 grey mixed-methods study. Of the four quantitative studies that reported on ME/CFS severity during pregnancy:

  • two suggested pregnancy negatively impacted on ME/CFS
  • one found most women had no change in ME/CFS symptoms and
  • one found ME/CFS improved;

this difference in symptom severity across studies was supported by the qualitative evidence.

The qualitative literature also highlighted the importance of individualised care throughout pregnancy and birth, and the need for additional support during family planning, pregnancy and with childcare.

Only one quantitative study reported on pregnancy outcomes, finding decreased vaginal births and higher rates of spontaneous abortions and developmental and learning delays associated with pregnancies in those with ME/CFS.

Conclusions

Current evidence on ME/CFS in pregnancy is limited and findings inconclusive. More high-quality research is urgently needed to support the development of evidence-based guidelines on ME/CFS and pregnancy.

STRENGTHS AND LIMITATIONS OF THIS STUDY

  • Thorough and systematic search for both peer-reviewed and grey literature relating to myalgic encephalomyelitis/ chronic fatigue syndrome and pregnancy that was not limited by date of publication.
  • Inclusion of both qualitative and quantitative evidence from both peer-reviewed and grey literature sources allowed us to explore different aspects of a complex research question.
  • Limited evidence was available, particularly peer-reviewed literature, which restricted the conclusions we were able to make in this study.
Posted in News | Comments Off on Research: ME/CFS & pregnancy

New NHS ME/CFS & Long COVID service in Cwm Taf Morgannwg UHB

Primary fatigue service, Cwm Taf MUHB

 

Cwm Taf Morgannwg University Health Board (CTMUHB) is the first health board in Wales to launch a service for post viral illness, which includes both ME/CFS and Long COVID. Who is the service for?

Anyone who lives in Bridgend, Merthyr Tydfil or Rhondda Cynon Taf with a diagnosis of ME/CFS or Long COVID can be referred to the Primary Fatigue Service (PFS).  You are advised to speak to your GP if you suspect you might have either of those conditions and they will do some investigations and blood tests to reach a diagnosis. They and other health professionals (consultant, nurse practitioner, occupational therapist, physiotherapist etc) can also refer you. Unfortunately you cannot refer yourself.

What will the service offer? 

Assessment – To begin with you will talk to a therapist to assess how your symptoms affect you, what you already do to manage them and what you would like to be able to do with your life. You will hopefully agree a plan of action. This could take up to an hour by phone, in a clinic, or if necessary, at home. The session will be tailored to the individual.

‘Treatments’ – you might be offered one to one sessions with either a physiotherapist or occupational therapist. A GP and psychologist are also available to advise if necessary. The length of the sessions will be tailored to your needs, up to 60 mins, and could be via the phone, in a clinic or in the home.

The approach will vary depending on the person, but it will often include support to deal with PEM such as how to find a baseline and get out of a boom/bust cycle, to pace and balance the energy envelope, to plan and prioritise.

Camau management programme – this series of sessions will take place in community venues in Bridgend, Pontypridd and Merthyr, and also online. They will introduce tools to help you manage your condition and include topics such as sleep, nutrition and finding some pleasure and quality of life. The aim is to help you gain the skills and knowledge to self-manage and live well with your condition.

Starting date?

The Service was launched on Monday 1 October 2023. GPs began to refer patients before that date so there could quickly be a waiting list!

WAMES have shared the needs, wishes and experiences of people with ME/CFS with the Service Team, but have not been consulted on the nature of the sessions they will offer. The organisers however are keen to get feedback on their service and the website. They emphasis that it is ‘a work in progress’.

We would be interested to hear the experiences of anyone who uses the Service. We will pass all comments, positive and negative, to the Service anonymously, unless specifically asked not to. In this way we can still influence how the service progresses and ensure that it meets the needs of people with ME/ CFS.  Contact jan@wames.org.uk

Find out more: Primary Fatigue Service / Gwasanaeth Blinder Sylfaenol

Posted in News | 1 Comment

ME/CFS Delivery plan: Unhelpful language

Language can hurt

 

“The way language is used can frustrate or upset people who have ME/CFS.”

This is one of the discoveries made by the Working Group who have developed the draft English ME/CFS Delivery Plan:

My full reality: the interim delivery plan on ME/CFS

“This insight comes from personal experience, gathered by people with personal experience who have participated in the development process for the delivery plan on ME/CFS. The evidence has not been validated by the government but represents a flavour of what we have heard through our meetings and workshops.”

They give examples of how life with ME/CFS is often misunderstood and can lead to hurtful comments:

Chronic Fatigue Syndrome as an alternative description of ME/CFS

I’d love it if I could stay in bed all day

You’re just lazy”         “Yeah, I’m very tired too

Normal experience of illness is that people recover

My mum’s friend had that and she recovered

You should aim for full recovery

We can get you back to normal with some time and effort

The misconception that ME/CFS is a mental health condition, ‘all in the mind’ or that you can get better or overcome symptoms by the way you think

Maybe you should ask your doctor to put up your dose of antidepressants

If you thought differently, you would get better

It helps to have a positive attitude

The fact that there is no medical test to prove that someone has ME/CFS

good news – the tests say there is nothing wrong with you

you are lying

maybe you are depressed about something

‘Post-exertional malaise’ or PEM is a technical term which most people will not have heard of

You did nothing yesterday, why are you still in bed?

Symptoms of ME/CFS cannot be seen

You look normal”       “You just don’t want to work

You don’t need the wheelchair because I saw you walk last week

No, you can’t have a home visit

People with mild or moderate ME/CFS can manage their energy to do something out of their ordinary routine, as long as they rest before and afterwards as necessary

How can you go for lunch with someone, but you can’t go to work for 8 hours?

The tests are only available in the mornings

We need you to commit to attending weekly

Read the full report: Language use in relation to ME/CFS – a personal perspective

Posted in News | Comments Off on ME/CFS Delivery plan: Unhelpful language

500 miles for ME: Carer Rob raises £1,000 for WAMES!

500 miles for ME – Rob raises £1,00 for WAMES

 

Rob began his challenge in June –  to walk 500 miles for ME over the course of 100 days, to greet the sunrise at Paxton’s Tower, near Carmarthen.

 

He is now three quarters of the way along. He has faced a wide range of weather, and a knee injury, and been joined by friends and family.

He “feels lucky to be doing something people with ME can’t” as so many are in the “slow lane”, [though Ffion in her poem reminds us that some of us are not even in the slow lane but “on the hard shoulder!”]

We are grateful to people who have supported Rob and donated:

WAMES  £1,000

ME Research UK  £1,343

Invest in ME Research £1,230

And Rob’s fundraising challenge is not over yet! Donate here

He is also taking time to record interviews, “raising awareness and educating about this debilitating disease that has for too long been neglected, resulting in #millionsmissing from their own lives.” Herre is a clip from his interview with Jan Russell about the work of WAMES in Wales.

So far there have been 3 Discussions at Dawn with

Rob has taken on this challenge on top of caring for his youngest son, who is currently bedbound. Fortunately he has the support and technical expertise from other family members, to whom we can thank for his online presence:

500 miles for ME web page      Discussions at dawn

Facebook: 500miles4ME      Twitter/X: @500miles4ME 

 

Posted in News | Comments Off on 500 miles for ME: Carer Rob raises £1,000 for WAMES!

MEA finds low opinion of NHS services for ME in Wales

MEA Count ME In survey of  health and social care for ME/CFS and Long COVID 

 

7,303 people in the UK completed the ME Association’s survey:

  • 85% (6,208 people) had a diagnosis of ME/CFS
  • 10% (730) had a diagnosis of Long Covid
  • 5% (365 people) were undiagnosed but experienced the 4 core symptoms of ME/CFS

In general, experiences with the NHS were more likely to be rated poor than good and were worse for ME/CFS than Long Covid:

  • Only 8% of those with ME/CFS rated the NHS as good or excellent, and with Long Covid it was 15%.
  • Top barriers to good care were long waiting times, not being listened to or believed, and ineffective treatments.
  • Every region in the UK scored badly. More than 50% of regions received a very poor or poor opinion. Wales, Northern Ireland, West Midlands, Southeast England, and Scotland received over 65%.
  • There are many barriers to receiving a timely diagnosis – the main ones being that people were diagnosed with a different condition, not being referred to specialists by GPs, long waits for tests or referrals, and not being taken
    seriously.

In Wales

69% of survey participants said that the support they had received from the NHS for ME/CFS was poor or very poor.

Only 35% of Welsh participants found the specialist services for ME/CFS to be good or excellent [We don’t know what these ‘specialist services’ in Wales were!]

WAMES will be bringing these results to the attention of the Health Boards in Wales as they work to develop services for people with ME/CFS. Please let us know if you see any improvement in the service you get from GPs or other health and social care professionals. Contact jan@wames.org.uk or any member of the team.

#ImplementNICE mecfs

Read the full MEA survey results

Posted in News | Comments Off on MEA finds low opinion of NHS services for ME in Wales

Energy Limiting Conditions: challenging disbelief & disregard (2)

Disbelief and Disregard in health and social care for people with Energy Limiting Conditions (ELC) Part 2

 

A research project into Energy Limiting Conditions (ELC) wanted to understand the problems people experience getting the support they need from health and social care services.

Part 2 of the research highlights the psychological harms experienced by the participants due to discrimination.

“disbelief made me feel worthless”: the impact of poor healthcare on mental health and wellbeing

Disbelief and Disregard Damages People’s Mental Health

Experiences of “medical gaslighting” left participants feeling traumatised, distressed, and depressed. Participants explained how being disbelieved when they sought medical help made them
question their “value”, core beliefs and self-knowledge.

Disbelief and Avoidance of Medical Care

Being disbelieved erodes the trust that patients have in healthcare professionals. Routine disbelief and disregard become routine experiences, they become reluctant to seek help and they begin to avoid medical encounters as much as possible, leading to worsening health.

Impact of Disbelief on Relationships with Friends and Family

In addition to the breakdown in relationships with healthcare professionals, participants also explained how the disbelief of healthcare professionals, amplified through the media, has a negative impact on relationships with friends and family.

Recommendations – A pathway to Equality:

  • The medical profession must listen and believe
  • Better patient pathways and quality of care are needed for people with ELC.
  • Training of all health, social care, and welfare professionals must include information about energy limiting conditions.
  • Institutional sexism in health, social care and welfare systems must be tackled along with racism, ageism, homophobia, ableism, transphobia, fatphobia etc.
  • Simpler ways for people with ELC to access support in welfare, social care, employment and education are needed.
  • People with ELC must be part of conversations about policy and practice that affects them, and equal partners in research on ELC.

Read more about the psychological harms

An introduction to ELCs & the Disbelief and Disregard project

Disbelief and disregard project website

Posted in News | 1 Comment

#DecodeME DNA study – the final push!

#DecodeME – sign up by 15 November 2023

 

It is now one year since the launch of the world’s largest DNA study for ME/CFS and the #DecodeME team have announced the final date to sign up.

MORE participants are needed!

and 4,000 spit tests are still to be returned.

The team say:

Thank you to everyone who has participated in the study so far. We couldn’t do it without you!

We are now in the final stage of participant recruitment and, if you haven’t already done so, you have until the 15th of November 2023 to complete your online questionnaire.

Click here to take part

At 5pm on the 15th of November, we will be closing our registration portal to both new participants and to those who have signed up but not completed their questionnaire.

Participants, who sign up and complete their questionnaire by the 15th of November deadline, and who are invited to participate in the DNA stage of the study, will be sent a spit collection kit. Final deadline for posting these back to DecodeME is the 31st of January 2024. As there can be unpredictable delays with the post, especially over the holiday season, please post your kit back to us as soon as possible and before this date, if you can.

This is the last call to sign up and be part of the DecodeME study.

Please join those in the ME/CFS community who are doing something extraordinary by taking part.

Almost 25,000 people have already signed up and completed their questionnaire, and almost 20,000 participants have also been invited to provide a DNA sample. This is great news, thank you to everyone who has participated!

However, we still need more people

and this is the last chance to be part of this ground-breaking study. So, if you, or someone you know, are 16 or older, live in the UK and have a diagnosis of ME/CFS, please do take part now to help us decode ME/CFS.

Finally, we currently have over 4,000 spit kits that have been sent out and not yet returned. If you have received your kit, but have not yet returned it, please send it back to us as soon as possible. If you have questions about returning your sample, then our FAQ page has a number of answers that might prove useful. Each sample returned will strengthen the results of our research, so we appreciate every kit sent back.

If you have been waiting more than three weeks for your kit, since receiving an invite to take part in the DNA stage, please contact the DecodeME team, email info@decodeme.org.uk team or on 0808 196 8664, and we will investigate and order you a replacement kit, if required. The final deadline for requesting replacement kits is the 15th of November 2023.

So, if you are yet to complete your questionnaire or haven’t yet signed up as a participant in the DecodeME study, but would like to do so, please visit www.decodeme.org.uk/portal before the 15th of November.

Thank you for supporting the study,

Warmest wishes,    The DecodeME Team

Read more:

Initial findings from the DecodeME questionnaire data published:

Being female, older and ill for longer increase the chance of greater severity

Posted in News | Comments Off on #DecodeME DNA study – the final push!